Ultimate magazine theme for WordPress.

Instadose Pharma Corp. (OTC MKTS: INSD) Growing “global sales platform”

Instadose Pharma Corp. (OTC-MKTS: INSD) is growing so fast that investors are adopting it. Twice in the past two weeks, Profit Takers have enjoyed INSD’s exponential growth.

This is a profitable short and long term plan for the cultivation of medicinal cannabis and cannabinoid oil and for global marketing.

Yesterday this worldwide breeder and marketer of medicinal cannabis and cannabinoid oil closed 13.04% at $ 24.61. It saw another profit-taking session last week on Tuesday. All of this is good and profitable news. INSD stock doubled last month from $ 12.25 on October 20 to $ 25.25.

Investors watch in awe. The stock is trading above its 50-day and 200-day moving averages. Prior to its reverse merger on September 24th, it was a no-business mailbox company. In January it was only a 0.10-cent share.

INSD continues its spectacular run. In a week it sprinted to a green jump of + 72%. The stock rose from $ 3 to $ 60 since mid-September.

The reason for INSD is that it creates JV partnerships worldwide. New ones are announced weekly. Looking for more. It is expanding its “Global Distribution Platform” for the growing cultivation and international sale of medicinal cannabis and cannabinoid oil.

All of this signals more growth as it penetrates deeper into the continents it operates on and adds more nations. It is already represented on five continents, including North and South America, Europe’s EU, India / Asia and South Africa / Congo.

Most recently INSD:

• Expand its presence in Africa by signing a JV partnership with Cameroon. The transaction further expands its “Global Distribution Platform” to Africa.

Cameroon has agreed to grow, cultivate, process and produce medical cannabis. According to Grant Sanders, Chairman of Instadose Canada, it is an ideal addition to the platform as it offers port access and ideal growing conditions.

  • Appointed to Sanctum Healthcare Remedies Private Limited, its Indian JV partner. In return, Sanctum agrees to grow, cultivate and sell medicinal cannabis and cannabinoid oil to Europe. It will be marketed to Europe through INSD’s “Global Distribution Platform”, INSD said.

• INSD is looking for more JV partners in countries like Egypt and Mexico. INSD posted a tweet last week about its progress in Mexico.

  • The catalyst for INSD and its goal is to open a commercial “gateway” to a new wholesale marketplace. It would provide medical cannabis to pharmaceutical companies that are receiving consistent, high quality, and affordable supplies of medical cannabis and cannabinoid oil.
  • INSD focuses on its three cultivation and cultivation centers in: Democratic Republic of the Congo (DRC), South Africa and Mexico.

Instadose Pharma Corp. (OTC-MKTS: INSD). It would gain global access to a new wholesale market worldwide through its global distribution platform.

This wholesale marketplace would then offer an inexpensive product as a bulk and active ingredient. It would be big, sustainable, consistent, diverse and of high quality.

These products, in turn, would be used in large quantities as active pharmaceutical ingredients. INSD is becoming a force in medical cannabis worldwide. it is negotiating additional JV partnerships to expand its global sales platform.

INSD Chairman Grant Sanders said, “The commercialization of cannabis will have a major impact on countries where it can be grown outdoors, especially in the developing world. The hope is that these countries will benefit from the development of a global medical cannabis market. “

INSD’s Global Distribution Platform is also geared towards sustainable, long-term agreements. The aim is to give something back to people and the environment. Instadose aims to increase fresh water, jobs, education, nutrition, quality of life and safety.

Grant Sanders, Chairman of Instadose Canada, describes its international joint ventures as strategic. You give Instadose open fields for cultivation. They also complement INSD’s network of established sales locations.

Keep INSD on the watchlist for medicinal cannabis and cannabinoid oil stocks. It is growing fast and investors are learning that it is a profitable short and long term game.

This article is part of a sponsored investor education program.

Comments are closed.